Logo DoctorsConnect

Your medical data, safe and secure.

Name

ATL1101

Description

ATL1101 is a second-generation antisense drug designed to block the synthesis of the IGF-1 receptor, a protein involved in the regulation of cell overgrowth in psoriasis. ATL1101 is being developed as a cream for the topical treatment of mild to moderate cases of psoriasis.

Brands

No brand information found.